When was the name change from Hancock Jaffe to enVVeno Medical Corporation?
Our name was changed on October 1, 2021.

What is enVVeno Medical Corporation’s stock symbol?
Our stock is traded on the Nasdaq under the symbol NVNO.

When was enVVeno Medical Corporation incorporated?
December 22, 1999

When did enVVeno Medical Corporation become a public company?
May 31, 2018

Where is enVVeno Medical Corporation located?
70 Doppler
Irvine, CA 92618

When is enVVeno Medical Corporation’s fiscal year end?
December 31st

Who is enVVeno Medical Corporation’s transfer agent?

Equiniti Trust Company, LLC (EQ) is enVVeno Medical Corporation’s transfer agent.  EQ’s automated telephone support services are available 24 hours per day, seven days per week.

EQ may be contacted as follows:

Mailing Address:
Equiniti Trust Company, LLC.
Attention: enVVeno Medical Corporation
55 Challenger Road, 2nd Floor
Ridgefield Park, NJ 07660

An EQ shareholder services representative can be reached at (800) 937-5449 between the hours of 8 a.m. and 8 p.m. Eastern Time, Monday through Friday. An Interactive Voice Response System is available 24 hours a day, seven days a week.

Shareholders can access information on EQ’s website at https://equiniti.com/us/ast-access

Shareholders can email inquiries to [email protected]

Who is enVVeno Medical Corporation’s independent auditor?
Marcum LLP
730 3rd Avenue
11th Floor
New York, NY 10017
[email protected]
P: 212.485.5500

Who is enVVeno Medical Corporation’s outside legal counsel?

Ellenoff Grossman
& Schole LLP
18101 Von Karman Avenue
Suite 230
Irvine, CA 92612
P: (212)370-1300
The VenoValve® and enVVe® are investigational medical devices currently in development. Neither device is approved or cleared for any indication in any market. The VenoValve® is only available for use in the United States in pre-market clinical studies.